These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4144099)

  • 21. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hemodynamic effects of a new inhibitor of adrenergic beta receptors (LB 46)].
    Lejwi G; Fabiato A; Gut JP; Gourgon R
    Arch Mal Coeur Vaiss; 1971 Nov; 64(11):1654-68. PubMed ID: 4402388
    [No Abstract]   [Full Text] [Related]  

  • 23. The pharmacology of practolol, a cardioselective beta adrenergic blocking drug.
    Fitzgerald JD
    Acta Cardiol; 1972; Suppl 16():1-18. PubMed ID: 4405742
    [No Abstract]   [Full Text] [Related]  

  • 24. New N-isopropyl and N-tert.-butyl-phenoxypropanolaminic derivatives having -adrenolytic, anti-arrhythmic and local anaesthetic activity.
    Marmo E; Caputi AP; Saini RK
    Arzneimittelforschung; 1972 Jul; 22(7):1109-17. PubMed ID: 4404342
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiarrhythmic activity of 1-(di-2,6-xylylmethoxy)-3-(isopropylamino) propanol-2-hydrochloride (BS-7977-d) in the dog heart lung preparation.
    Laddu R
    Eur J Pharmacol; 1970 Feb; 9(2):129-35. PubMed ID: 4392344
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative studies on the effect of 2 beta receptor blockaders on elevated blood pressure and kidney function].
    Anlauf M; Heimsoth V; Ulrych M; Bock KD
    Verh Dtsch Ges Inn Med; 1969; 75():169-72. PubMed ID: 4395389
    [No Abstract]   [Full Text] [Related]  

  • 28. -adrenergic blocking and cardiovascular properties of a new compound, 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol-hydrochloride (YB-2).
    Tanenaka T; Tachikawa S
    Arzneimittelforschung; 1972 Nov; 22(11):1864-9. PubMed ID: 4144713
    [No Abstract]   [Full Text] [Related]  

  • 29. Myocardial effects of phentolamine.
    Das PK; Parratt JR
    Br J Pharmacol; 1970 Sep; 40(1):150P-151P. PubMed ID: 4395081
    [No Abstract]   [Full Text] [Related]  

  • 30. Coronary vasomotor responses to cardiac sympathetic nerve stimulation in the dog treated with beta adrenoceptor blocking agents.
    Takenaka F; Ishihara T
    Jpn J Pharmacol; 1972 Oct; 22(5):721-3. PubMed ID: 4405463
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of oxprenolol (Trasicor, Ciba 39089-Ba) on patterns of urinary sodium excretion in man.
    Singh BN; Till MR; Kelly DT
    Am J Cardiol; 1971 Apr; 27(4):372-5. PubMed ID: 4396725
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experience with the use of the beta-receptor blocker practolol (Dalzic) in anesthesia (gynecology)].
    Schilling K
    Z Prakt Anasth Wiederbeleb Intensivther; 1972 Dec; 7(6):367-77. PubMed ID: 4405592
    [No Abstract]   [Full Text] [Related]  

  • 34. Systemic and coronary hemodynamic effects of pronethalol practolol, sotalol and D-propranolol.
    Rowe GG; Berndt TB; O'Brien GS; Afonso S
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):5-24. PubMed ID: 4404935
    [No Abstract]   [Full Text] [Related]  

  • 35. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-blocking drugs and human platelet aggregation in vitro.
    Gibelli A; Montanari C; Bellani D; Mandelli V; Sacchetti G
    Experientia; 1973 Feb; 29(2):186-7. PubMed ID: 4144249
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiopulmonary actions of 1-isopropylamino-3-(3-tolyloxy)-2-propanol hydrochloride: a new adrenergic beta receptor antagonist.
    Madan BR; Gupta RS; Santani DD
    Indian J Med Res; 1970 Feb; 58(2):246-52. PubMed ID: 4394157
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 39. The assessment of -adrenoceptor blocking potency and cardioselectivity in vitro and in vivo.
    Baird JR; Linnell J
    J Pharm Pharmacol; 1972 Nov; 24(11):880-5. PubMed ID: 4405651
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacology of M & B 17803A in man and dog.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1971 Oct; 43(2):468P-469P. PubMed ID: 4400577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.